TAKEDA PHARMACEUTICAL CO LTD

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Tokyo, Japan
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Max Heuer, Authorized Signatory, Takeda Pharmaceutical Company Limited
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for TAKEDA PHARMACEUTICAL CO LTD

Form 4 holding 10%+ Owner

Xilio Therapeutics, Inc.

Security class
Common Stock
Shares / value
1,475,121
Estimated value
$1,224,350
Report date
26 Oct 2021
Price
$0.8300
Ownership
Indirect
Form 4 holding Former 10% Owner

Calithera Biosciences, Inc.

Security class
Series A Convertible Preferred Stock
Shares / value
0
Estimated value
Report date
17 Apr 2023
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Ovid Therapeutics Inc.

Security class
Series A Convertible Preferred Stock
Shares / value
0
Estimated value
Report date
08 Dec 2025
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Theseus Pharmaceuticals, Inc.

Security class
Series A Preferred Stock
Shares / value
0
Estimated value
Report date
12 Oct 2021
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Xilio Therapeutics, Inc.

Security class
Series B Preferred Stock
Shares / value
0
Estimated value
Report date
26 Oct 2021
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Xilio Therapeutics, Inc.

Security class
Series C Preferred Stock
Shares / value
0
Estimated value
Report date
26 Oct 2021
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by TAKEDA PHARMACEUTICAL CO LTD

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .